Sorted By:

Relevance


Senior Director – State Policy (Mid-Atlantic/Southeast Region)

PhRMA  |  PhRMA Career

Preferred Previous experience working in a state government/legislature policy role, national trade association, or the pharmaceutical industry; Advanced degree in Law, Business, Health Policy, Public Policy, or related field.
https://www.phrma.org/careers/senior-director-state-policy-mid-atlantic/southeast-region

Senior Director – State Policy (New England Region)

PhRMA  |  PhRMA Career

Preferred Previous experience working in a state government/legislature policy role, national trade association, or the pharmaceutical industry; Advanced degree in Law, Business, Health Policy, Public Policy, or related field.
https://www.phrma.org/careers/senior-director-state-policy-new-england-region

2017 State of Vaccines

PhRMA  |  Report

Stakeholders across the ecosystem are working together to advance new vaccine technology that has the potential to prevent and even treat many devastating diseases. 
https://www.phrma.org/report/2017-state-of-vaccines

Exchanges State Map

PhRMA  |  From PhRMA

Take a look at the state map below to view key facts about 2016 health plans and prescription drug coverage in your state's health insurance exchange. 
https://www.phrma.org/media/exchanges-state-map

Senior Director – State Policy (Pacific Northwest Region)

PhRMA  |  PhRMA Career

Preferred Previous experience working in a state government/legislature policy role, national trade association, or the pharmaceutical industry; Advanced degree in Law, Business, Health Policy, Public Policy, or related field.
https://www.phrma.org/careers/senior-director-state-policy-pacific-northwest-region

Manager – Advocacy and Strategic Alliances (State)

PhRMA  |  PhRMA Career

Identify areas of opportunities and develop strategies to advance industry priorities at the state level.  
https://www.phrma.org

Programs and Initiatives

PhRMA  |  From PhRMA

Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. 
https://www.phrma.org/resources/state-map/stem

Clinical Trials

PhRMA  |  From PhRMA

Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. 
https://www.phrma.org/resources/state-map/clinical-trials

Economic Impact

PhRMA  |  From PhRMA

Explore the interactive map below and select a state to access data on biopharmaceutical jobs, the industry's overall economic impact, clinical trial activity, and more. 
https://www.phrma.org/resources/state-map

A state-by-state look at coverage and access hurdles in 2016 exchange plans

PhRMA  |  Blog Post

Be sure to look up your state here, and learn more at AccessBetterCoverage.org.
http://catalyst.phrma.org/a-state-by-state-look-at-coverage-and-access-hurdles-in-2016-exchange-plans

Understanding Health Insurance Exchanges State-by-State

PhRMA  |  Blog Post

” Check out the map and learn more about coverage, deductibles, and cost-sharing in your state.
http://catalyst.phrma.org/understanding-health-insurance-exchanges-state-by-state

Director – State Advocacy

PhRMA  |  PhRMA Career

Meet with legislators, governors, and state agency leads and their staff as needed. 
https://www.phrma.org/careers/director-state-advocacy

Mae Jemison

PhRMA  |  Biography

Among many honors, awards and honorary degrees she received the National Organization for Women’s Intrepid Award, the Kilby Science Award and in 1999 was selected as one of the top seven women leaders in a presidential ballot national straw poll.
https://www.phrma.org/biography/mae-jemison

How drug importation schemes could increase U.S. law enforcement burdens

PhRMA  |  Blog Post

Here are a few examples of how drug trafficking and importation proposals can impact law enforcement: Disrupting just one designer drug distribution ring that produced synthetic opioids involved law enforcement from 45 states and joint operations in 4 other countries, including Australia, New Zealand, Canada and Barbados.
http://catalyst.phrma.org/how-drug-importation-schemes-could-increase-u.s.-law-enforcement-burdens

Restrictive State Medicaid Preferred Drug Lists May Reduce Adherence and Lead to Poor Outcomes

Chartpack  |  From Our Network

In Alabama, 51% of patients discontinued statin therapy after preferred drug list (PDL) restrictions were imposed, compared to 39% in the previous period....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicaid/restrictive-state-medicaid-preferred-drug-lists-may-reduce-adherence-and-lead-to-poor-outcomes

Scott LaGanga to Lead PhRMA State Advocacy; Shannon Graham to Lead Strategic Alliances

PhRMA  |  Press Release

Prior to her current role with PhRMA, Graham was manager of state advocacy and alliance development for GlaxoSmithKline (GSK), where she collaborated with colleagues across the country to help broaden partnerships and community impact.
https://www.phrma.org

State Leaders See Bioscience as Jobs Engine

PhRMA  |  Blog Post

They understand how this innovative industry can be a leader both in creating great medicines to help fight disease and also in strengthening our states', local and national economy.
http://catalyst.phrma.org/state-leaders-see-bioscience-as-jobs-engine

Executive Assistant – Law Department

PhRMA  |  PhRMA Career

Equal Opportunity Employer  PhRMA provides equal employment opportunities to all applicants without regard to race, color, religion, national origin, sex, age, marital status, personal appearance, sexual orientation, gender identity or expression, family responsibilities, genetic information, disability, matriculation, political affiliation or veteran status in accordance with applicable federal, state and local laws governing non-discrimination in employment. 
https://www.phrma.org

PhRMA on the State of the Union Address

PhRMA  |  Press Release

“We will continue to work with the Administration and members of Congress on bipartisan solutions that can help spur growth in the U.S. economy, ensure patient access to new medicines, and foster future development of life-saving medicines.”
https://www.phrma.org/press-release/phrma-on-the-state-of-the-union-address

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

PhRMA  |  Blog Post

There’s no denying that the talented individuals working within the Bay Area will be at the forefront of game-changing discoveries in our industry, transforming the innovation pipeline as we know it.
http://catalyst.phrma.org/putting-the-bio-in-biotech-how-bay-area-minds-are-powering-biopharmaceutical-innovation

PhRMA on the State of the Union Address

PhRMA  |  Press Release

“We will continue to work with the Administration and members of Congress on bipartisan solutions that can help spur growth in the U.S. economy, ensure patient access to new medicines, and foster future development of life-saving medicines.”
https://www.phrma.org/press-release/phrma-on-the-state-of-the-union-address1

Statement to State of the Union Address

PhRMA  |  Press Release

Biopharmaceutical sector R&D investment should be fostered, not singled out for destructive policies."
https://www.phrma.org/press-release/statement-to-state-of-the-union-address

PhRMA Statement on the State of the Union Address

PhRMA  |  Press Release

However, continued medical progress can only be realized if policymakers support the critical work that innovators do to help improve the health of millions of patients today and tomorrow.
https://www.phrma.org/press-release/phrma-statement-on-the-state-of-the-union-address

PhRMA Statement on State of the Union

PhRMA  |  Press Release

“We will continue to work with the Administration and members of Congress, on both sides of the aisle, on bipartisan solutions that can help spur growth in the U.S. economy, preserve timely patient access to new medicines, maintain market-based competition and foster future development of life-enhancing and life-saving treatments.”
https://www.phrma.org/press-release/phrma-statement-on-state-of-the-union

New Report: Clinical Trials and the Impact on State Economies

PhRMA  |  Blog Post

The nationwide economic impact associated with the industry as a whole – including non-R&D activities such as manufacturing and distribution – has been well documented in recent years. 
http://catalyst.phrma.org/new-report-clinical-trials-and-the-impact-on-state-economies

You have reviewed the first 25 results out of 2148. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next